We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Lipidomic Determinants Profiled for Human Diabetic Neuropathy

By LabMedica International staff writers
Posted on 05 Oct 2022
Print article
Image: The Thermo Fisher Scientific Orbitrap Velos mass spectrometer features dual-pressure linear ion trap technology that delivers increased sensitivity and dynamic range with ultimate robustness (Photo courtesy of University of Michigan)
Image: The Thermo Fisher Scientific Orbitrap Velos mass spectrometer features dual-pressure linear ion trap technology that delivers increased sensitivity and dynamic range with ultimate robustness (Photo courtesy of University of Michigan)

Peripheral neuropathy is a common complication of type 2 diabetes, ranging in prevalence from 10% to over 50% in various cohorts. Peripheral neuropathy symptoms manifest as a loss of sensation and pain in a length-dependent manner. Peripheral neuropathy in type 2 diabetes remains recalcitrant to effective treatment; glucose control only marginally prevents neuropathy onset and development.

Numerous studies have provided evidence that obesity and dyslipidemia are important neuropathy risk factors, independent, even, of glycemic status. In these investigations, measurements were limited to a basic lipid profile. Recent mass spectrometry advances allow the identification and quantification of a larger array of lipids, termed the lipidome, from biosamples.

Neurologists at the University of Michigan (Ann Arbor, MI, USA) and their colleagues carried out a study of 17 males and 52 females with a mean age of 45 years ± 9 years, from the Gila River Indian community with type 2 diabetes. Neuropathy was assessed10 years later using the combined Michigan Neuropathy Screening Instrument (MNSI) examination and questionnaire scores. A combined MNSI index was calculated from examination and questionnaire scores.

Samples were prepared and mass spectrometry quantified lipids from 18 classes as per published protocols. Four hundred and thirty-five lipids were quantitated from the 18 classes. Classes that consisted of two or fewer lipid species (monoacylglycerols, plasmenyl-phosphatidylcholines, phosphatidic acids, phosphatidylglycerols, phosphatidylserines, and ceramide phosphates) were eliminated. After combining the different mass spectrometry adducts of the same feature, 236 unique lipids were included in the final analysis.

The investigators stratified the participants were as with (high MNSI index score > 2.5407) versus without neuropathy (low MNSI index score ≤ 2.5407). Significantly decreased medium-chain acylcarnitines and increased total free fatty acids, independent of chain length and saturation, in serum at baseline associated with incident peripheral neuropathy at follow-up, that is, participants had high MNSI index scores, independent of covariates. Participants with neuropathy also had decreased phosphatidylcholines and increased lysophosphatidylcholines at baseline, independent of chain length and saturation. The abundance of other lipid classes did not differ significantly by neuropathy status.

Eva L. Feldman, MD, PhD, Professor of Neurology and senior author of the study, said, “We have the potential to test for these lipid biomarkers in patients with type 2 diabetes to identify those with the highest risk of developing peripheral neuropathy and facilitate more focused management of those patients. Our findings support the concept that unsaturated healthy fats are a better source of energy for nerves that highly saturated fats. We strongly recommend a Mediterranean-type diet to maintain a healthy nervous system.”

The authors concluded that aggregate abundance differences in circulating medium-chain acylcarnitines, free fatty acids, phosphatidylcholines, and lysophosphatidylcholines, early in the course of the disease are linked to the later development of human type 2 diabetic neuropathy. The study was published in the September, 2022 issue of the journal Annals of Clinical and Translational Neurology.

Related Links:
University of Michigan 

New
Gold Supplier
PCR Microplate
SAPPHIRE MICROPLATE
New
Silver Supplier
Auto Molecular Diagnostic System
ELITe InGenius
New
TSH (Thyroid Stimulating Hormone) Test
Kemilo TSH Kit
New
Radiotherapy Toxicity Measurement Assay
Radiotherapy Toxicity Measurement Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.